Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)
Latest Information Update: 10 Feb 2023
At a glance
- Drugs Nesiritide (Primary)
- Indications Acute heart failure; Decompensated heart failure
- Focus Registrational; Therapeutic Use
- Acronyms ASCEND-HF
- Sponsors Janssen-Cilag; Scios
- 01 Jan 2023 Results (n=5741) comparing NYHA Class and patient-reported health outcomes in cohort of patients hospitalized for heart failure, majority of patients exhibited discordance between clinician-reported NYHA class published in the Circulation: Heart Failure
- 01 Dec 2022 Results of an analysis comparing patient-reported and clinical outcomes between patients hospitalized with HFrEF vs HFpEF published in the Journal of Cardiac Failure
- 07 Nov 2022 Results (n=5741) Comparing Patient Reported Outcomes and New York Heart Association Class Among Patients Hospitalized for Heart Failure presented at the American Heart Association Scientific Sessions 2022